HWLAX
Price
$48.79
Change
+$0.24 (+0.49%)
Updated
Jul 10 closing price
Net Assets
372.16M
VIVIX
Price
$85.56
Change
+$0.04 (+0.05%)
Updated
Jul 13 closing price
Net Assets
254.46B
Interact to see
Advertisement

HWLAX vs VIVIX

HWLAX vs VIVIX Comparison Chart in %
View a ticker or compare two or three
VS
HWLAX vs. VIVIX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HWLAX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 254B vs. HWLAX (372M). VIVIX pays higher dividends than HWLAX: VIVIX (1.88) vs HWLAX (1.32). HWLAX was incepted earlier than VIVIX: HWLAX (25 years) vs VIVIX (28 years). HWLAX (1.18) is less costly to investors than VIVIX (0.03). HWLAX is a more actively managed with annual turnover of: 40.00 vs. VIVIX (8.00). HWLAX has a lower initial minimum investment than VIVIX: HWLAX (2500) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 23.05 vs. HWLAX (14.10). VIVIX return over 5 years is better than : 59.41 vs. HWLAX (20.80).
HWLAXVIVIXHWLAX / VIVIX
Total Expense Ratio1.180.033,933%
Annual Report Gross Expense Ratio1.180.033,933%
Fund Existence25 years28 years-
Gain YTD9.07714.77761%
Front Load5%N/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets372M254B0%
Annual Yield % from dividends1.321.8870%
Returns for 1 year14.1023.0561%
Returns for 3 years22.6953.8942%
Returns for 5 years20.8059.4135%
Returns for 10 years112.94151.5775%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BPYPO15.260.22
+1.46%
Brookfield Property Partners LP
STRC87.02-0.46
-0.53%
Strategy Inc Variable Rate Series A Perpetual Stretch Preferred Stock
EOLS6.52-0.09
-1.36%
Evolus
SANM201.80-6.99
-3.35%
Sanmina Corp
HRMY35.54-1.30
-3.53%
Harmony Biosciences Holdings